Simultaneous Therapy with Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema
暂无分享,去创建一个
[1] M. Mubasher,et al. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY , 2015, Retina.
[2] C. Sigouin,et al. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study , 2015, Clinical ophthalmology.
[3] Ahmed S. Gado,et al. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion‐related macular oedema: a prospective randomized comparison , 2014, Clinical & experimental ophthalmology.
[4] M. Gillies,et al. Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema , 2015, Therapeutic advances in chronic disease.
[5] A. Cruess,et al. Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus , 2015, Ophthalmologica.
[6] N. Vakalis,et al. Intravitreal Combination of Dexamethasone Sodium Phosphate and Bevacizumab in The Treatment of Exudative AMD , 2015, Scientific Reports.
[7] S. Whitcup,et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. , 2014, Ophthalmology.
[8] Ahmed S. Gado,et al. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion‐related macular oedema: a prospective randomized comparison , 2014, Clinical & experimental ophthalmology.
[9] S. Gupta,et al. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. , 2013, Ophthalmology.
[10] Angela M. Herro,et al. OPTICAL COHERENCE TOMOGRAPHY IN RETINITIS PIGMENTOSA: Reproducibility and Capacity to Detect Macular and Retinal Nerve Fiber Layer Thickness Alterations , 2012, Retina.
[11] A. Kampik,et al. Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema , 2012, Ophthalmologica.
[12] M. Blumenkranz,et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. , 2011, Ophthalmology.
[13] J. Kim,et al. Asymmetry of diurnal intraocular pressure fluctuation between right and left eyes , 2011, Acta ophthalmologica.
[14] N. Bressler,et al. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. , 2009, Archives of ophthalmology.
[15] G. Karakiulakis,et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. , 1998, European journal of pharmacology.